Form D · Hedge Fund

GMO Mean Reversion Special Solution Fund, L.P.

Boston, MA · CIK 0001624611

Offering snapshot reported Aug 7, 2015 · SEC filing

Reported sold
$628M
Indefinite offering
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 5, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$314M$628MJan 14, 2015: $628,349,105.00Jan 14, 2015Aug 7, 2015: $628,349,105.00Aug 7, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 7, 2015Amendment$628,349,105$0vs Jan 14, 20152SEC filing
Jan 14, 2015Initial$628,349,105No comparison2SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-232200

Source: Form D, filed Aug 7, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bradley J. Hilsabeck Director, Executive
Joseph B. Kittredge, Jr. Director, Executive
Jean Pierre Mittaz Director, Executive
Urban Carl Mueller Director
Tina Vandersteel Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Gmo Europe Llc 40 Rowes Wharf
Boston, MA, 02110